We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Edwards Lifesciences
EW
$53.6B
| $7.75M | 0.03% |
93,634
-3,608
| -4% | -$284K |
|
302
Gen Digital
GEN
$17.1B
| $7.7M | 0.03% |
448,781
-664,969
| -60% | -$13.3M |
|
303
Donaldson
DCI
$11.2B
| $7.48M | 0.03% |
+114,548
| New | +$7.2M |
|
304
Hawaiian Electric Industries
HE
$2.06B
| $7.39M | 0.03% |
192,461
+1,631
| +0.9% | +$66.1K |
|
305
BioMarin Pharmaceuticals
BMRN
$13.6B
| $7.36M | 0.03% |
75,709
-1,212
| -2% | -$126K |
|
306
Alliant Energy
LNT
$18.2B
| $7.31M | 0.03% |
136,933
-5,103
| -4% | -$271K |
|
307
Affiliated Managers Group
AMG
$9.57B
| $7.23M | 0.03% |
50,746
| – | – |
|
|
SWAV
308
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $7.21M | 0.03% |
33,244
-3,925
| -11% | -$765K |
|
309
Amdocs
DOX
$6.08B
| $7.17M | 0.03% |
74,653
+626
| +0.8% | +$57.9K |
|
|
SIX
310
DELISTED
Six Flags Entertainment Corp.
SIX
| $7.13M | 0.03% |
+266,890
| New | +$7.13M |
|
311
Emcor
EME
$36.8B
| $7.01M | 0.03% |
43,113
+21,334
| +98% | +$3.28M |
|
312
lululemon athletica
LULU
$13.7B
| $6.94M | 0.03% |
19,062
-27,258
| -59% | -$8.55M |
|
313
Jazz Pharmaceuticals
JAZZ
$16.2B
| $6.94M | 0.03% |
47,433
+28,839
| +155% | +$4.27M |
|
|
PDCE
314
DELISTED
PDC Energy, Inc.
PDCE
| $6.9M | 0.03% |
107,579
-189,566
| -64% | -$12.3M |
|
315
Chemed
CHE
$7.07B
| $6.59M | 0.03% |
12,251
-248
| -2% | -$126K |
|
316
Wells Fargo
WFC
$269B
| $6.57M | 0.03% |
175,784
-1,530,814
| -90% | -$66.7M |
|
317
Camden Property Trust
CPT
$10.9B
| $6.55M | 0.03% |
62,443
-40,634
| -39% | -$4.63M |
|
318
Snap-on
SNA
$21.1B
| $6.53M | 0.03% |
26,462
-6,864
| -21% | -$1.68M |
|
319
Tyson Foods
TSN
$19.6B
| $6.46M | 0.03% |
108,932
-755,028
| -87% | -$46.4M |
|
|
EA
320
DELISTED
Electronic Arts
EA
| $6.45M | 0.03% |
53,590
-37,387
| -41% | -$4.39M |
|
321
Trade Desk
TTD
$6.34B
| $6.37M | 0.03% |
104,641
-230,224
| -69% | -$12.3M |
|
322
IDEX
IEX
$17.7B
| $6.32M | 0.03% |
27,361
-740
| -3% | -$168K |
|
323
ZTO Express
ZTO
$17.6B
| $6.2M | 0.03% |
216,339
-30,228
| -12% | -$825K |
|
324
Sylvamo
SLVM
$1.53B
| $6.15M | 0.03% |
132,887
| – | – |
|
325
FedEx
FDX
$77.3B
| $6.12M | 0.03% |
26,772
+25,490
| +1,988% | +$5.18M |
|
Similar funds
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.